Discontinued — last reported Q3 '23
Linde Interest Paid remained flat by 0.0% to $137.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $110.75M to $137.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 23.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $233.00M | $170.00M | $451.00M | $443.00M | $548.00M |
| YoY Change | — | -27.0% | +165.3% | -1.8% | +23.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.